Daily versus weekly prostate cancer image-guided radiotherapy: Phase 3 multicenter randomized trial

The optimal frequency of prostate cancer image-guided radiation therapy (IGRT) has not yet been clearly identified. This phase 3 trial compared the efficacy of daily versus weekly IGRT. Compared to weekly control, daily control, by improving prostate targeting, decreases the risks of recurrences as well as rectal toxicity.

Source: International Journal of Radiation Oncology * Biology * Physics - July 30, 2018 Category: Radiology Authors: Renaud de Crevoisier, Mohamed Amine Bayar, Pascal Pommier, Xavier Muracciole, Fran çoise Pêne, Philippe Dudouet, Igor Latorzeff, Véronique Beckendorf, Jean-Marc Bachaud, Agnès Laplanche, Stéphane Supiot, Bruno Chauvet, Tan-Dat Nguyen, Alberto Bossi, Tags: Clinical Investigation Source Type: research